DCC Healthcare Acquired by Investindustrial in $1.05 Billion Deal
Deal News | Apr 22, 2025 | Finance Community IT - 3 Private Equity
Investindustrial, a private equity firm, has acquired DCC Healthcare from the DCC group in a transaction valued at £1.05 billion. Supported by Barclays and Moelis & Co as financial advisors, and law firms including Milbank and Paul Weiss, this acquisition aligns with Investindustrial's strategy to enhance growth through buy-and-build investments. DCC Healthcare, a division of the Irish-based and UK-listed DCC plc, deals in healthcare services, nutritional supplements, and medical devices. The transaction involves a deferred payment of £130 million over two years and is set to complete by Q3 2025. It paves the way for Investindustrial to leverage its expertise, particularly with its subsidiaries HBI and Vital, in expanding through organic growth and acquisitions. DCC's strategic divestment aligns with its focus on energy, following a strategic review initiated in November 2024.
Sectors
- Private Equity
- Healthcare
- Pharmaceuticals
Geography
- United Kingdom – DCC plc is listed in the UK, and the transaction is subject to UK market considerations.
- Ireland – DCC group is an Irish-registered company, highlighting the transaction's ties with Ireland.
Industry
- Private Equity – Investindustrial is a private equity firm executing strategic acquisitions to expand its investment portfolio.
- Healthcare – DCC Healthcare specializes in healthcare services, targeting areas like nutritional supplements and medical devices.
- Pharmaceuticals – The acquisition includes HBI, which focuses on innovative nutritional supplements, aligning with the broader pharmaceuticals sector.
Financials
- £1.05 billion – Total enterprise value of the DCC Healthcare acquisition by Investindustrial.
- £130 million – Deferred compensation to be paid over two years as part of the acquisition.
- £859.4 million – Revenue reported by DCC Healthcare for the fiscal year ending March 31, 2024.
- £88.1 million – Adjusted operating profit from DCC Healthcare for the fiscal year ending March 31, 2024.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Investindustrial | Buyer | Company | A private equity firm focused on strategic buy-and-build acquisitions. |
| DCC Healthcare | Target | Company | A division of DCC plc providing healthcare services. |
| DCC plc | Seller | Company | An Irish company listed in the UK, divesting its healthcare division. |
| Barclays | Financial Advisor | Company | Advised Investindustrial on the acquisition of DCC Healthcare. |
| Moelis & Company | Financial Advisor | Company | Assisted Investindustrial in financial advisory for the deal. |
| JP Morgan | Financial Advisor | Company | Advised DCC plc on financial matters regarding the transaction. |
| Milbank | Legal Advisor | Company | Provided legal advice to Investindustrial. |
| Chiomenti | Legal Advisor | Company | Legal advisors for Investindustrial in the acquisition. |
| Paul Weiss | Legal Advisor | Company | Part of the legal advisory team for Investindustrial. |
| Cleary Gottlieb | Legal Advisor | Company | Legal advisor for DCC plc in the deal. |
| William Fry | Legal Advisor | Company | Provided legal advisory services to DCC plc. |
| Andrea C. Bonomi | Commentator | Person | Chairman of the advisory board of Investindustrial. |